Se-cure Pharmaceuticals' manufacturing site has been audited and GMP approved by the Australian Government's Therapeutic Goods Administration (TGA) and Femarelle^® has been accepted as a TGA listed product. Femarelle^® is now ready to launch in Australia and Se-cure is searching for a marketing & distribution partner. For further information, please contact Tamar Barkan, VP Business Development, This e-mail address is being protected from spam bots, you need JavaScript enabled to view it .